
JP Morgan Week 2025 – Ryan Spencer
Join CEO Ryan Spencer of Dynavax Technologies in a video interview discussing JP Morgan Week 2025

Trial of Boehringer's cystic fibrosis gene therapy imminent
Boehringer's cystic fibrosis gene therapy is poised to start clinical testing, hoping to offer a one-shot alternative to costly CFTR modulator drugs.

NICE backs consolidation use of Blincyto in leukaemia
NICE backs NHS use of Amgen's Blincyto for the consolidation phase of treatment for some patients with acute lymphoblastic leukaemia.

Poolbeg slumps as Hookipa merger is called off
A proposed merger of the UK's Poolbeg with Austrian biotech Hookipa has been called off after the latter abruptly withdrew from negotiations.

AstraZeneca builds in China as Cosette buys Mayne
The reporting week has ended with a flurry of M&A as Cosette Pharma and AstraZeneca agree takeover deals.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content

2nd ADC Payload Summit
Diversifying ADC Payloads as Warheads for Overcoming Tumor Resistance, With Optimized Efficacy, Potency, Mechanisms & Differentiated IP

3rd Obesity & Weight Loss Summit
The 3rd Obesity & Weight Loss Drug Development Summit is the place to be for experts in weight loss drug development tackling the obesity epidemic.

6th Cytokine-Based Drug Development Summit 2025
With more cytokine-based drugs entering clinical trials and novel combination and masking technologies being used, there is a growing need for experts to discuss, understand, and build on t

7th Neuroimmunology Drug Development Summit
7th Neuroimmunology Drug Development Summit | February 25-27 2025 | Boston, MA

3rd Precision Medicine in Inflammatory Bowel Disease Summit ...
Following a year of exceptional progress in IBD drug development, fierce competition in clinical trials for Chron’s Disease and Ulcerative Colitis remains high, and it’s time for biopharma to push